@ARTICLE{
author={Robinson Michael F,Damjanov Nemanja S,Stamenkovic Bojana N,Radunovic Goran L,Kivitz Alan J,Cox Lori,Manukyan Zorayr,Banfield Christopher,Saunders Michael,Chandra Deepa,Vincent Michael S,Mancuso Jessica,Peeva Elena,Beebe Jean S},
year={2020},
title={Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={10},
pages={1621-1631},
document_type={Article},
} 

@ARTICLE{
author={Robinson Michael F,Damjanov Nemanja S,Stamenkovic Bojana N,Radunovic Goran L,Kivitz Alan J,Cox Lori,Manukyan Zorayr,Banfield Christopher,Saunders Michael,Chandra Deepa,Vincent Michael S,Mancuso Jessica,Peeva Elena,Beebe Jean S},
year={2020},
title={Efficacy and Safety of PF-06651600 (Ritlecitinib), a Novel JAK3/TEC Inhibitor, in Patients With Moderate-to-Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate},
journal={ARTHRITIS & RHEUMATOLOGY},
volume={72},
number={10},
pages={1621-1631},
document_type={Article},
} 

@ARTICLE{
author={Damjanov Nemanja S,Tlustochowicz Malgorzata,Aelion Jacob,Greenwald Maria,Diehl Annette,Bhattacharya Indranil,Peeva Elena,Menon Sandeep,Gourley Ian},
year={2016},
title={Safety and Efficacy of SBI-087, a Subcutaneous Agent for B Cell Depletion, in Patients with Active Rheumatoid Arthritis: Results from a Phase II Randomized, Double-blind, Placebo-controlled Study},
journal={JOURNAL OF RHEUMATOLOGY},
volume={43},
number={12},
pages={2094-2100},
document_type={Article},
}